Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJonsson Comprehensive Cancer Center

About this trial

This study is being done to help researchers learn more about and successfully diagnose cancer using blood samples and tissue samples from surgeries in patients with suspicious thyroid nodules or thyroid cancer. Diagnosing cancer in this way, as opposed to biopsies, may be less invasive to the patient. Analyzing blood and tissues samples may also help researchers to differentiate non-cancerous tumors from thyroid cancer and detect high-risk mutations to guide treatment.

Eligibility criteria

Qualifiers

Aged 18 and older

Consented for thyroid surgery for thyroid cancer or indeterminate thyroid nodule

Disqualifiers

Patients with concurrent malignancy

Trial design

Treatments tested in this trial

  • Biospecimen Collection
  • Electronic Health Record Review

Treatment groups

250 Participants
are divided into 1 treatment group